Search  Follow Investorideas on Twitter  Investorideas is on Facebook  Investorideas is on Google Plus  Investorideas is on Youtube  Investorideas is on Pinterest  Investorideas is on tumblr  Investorideas is on LinkedIn  Investorideas RSS



BiodefenseStocks.com - A Leading Global Website for Biodefense Stocks

BioDefenseStocks.com - investing ideas in biodefense stocks

Like Biodefense Stocks? View our Biodefense Stocks Directory


Featured biotech stocks

Aethlon Medical, Inc.

(NasdaqCM:AEMD)


Aethlon Medical (NasdaqCM:AEMD) is a leading developer of immunotherapeutic technologies to combat infectious disease and cancer. To augment the body's natural immune defenses, the Aethlon Hemopurifier® eliminates life-threatening disease targets that are often shielded from the immune system and not well addressed by traditional drug therapies. The technology captures circulating viruses, bacterial toxins and cancer promoting exosomes through affinity attachment to a unique structure that cloaks these targets from immune detection. At present, the Hemopurifier® is being advanced under an FDA approved clinical study. Aethlon is also the majority owner of Exosome Sciences, Inc., a company focused on the discovery of exosomal biomarkers to diagnose and monitor life-threatening diseases.

Featured biotech properties

Defense and Security News

#Defense Stock News: Cubic's (NYSE: $CUB), GATR Technologies Receives Most Innovative New Product Award from CONNECT
SAN DIEGO - December 2, 2016 (Investorideas.com Newswire) Cubic Corporation (NYSE: CUB), today announced that its subsidiary GATR Technologies (GATR), which operates within the Cubic Mission Solutions (CMS) business division, received the Most Innovative New Product (MIP) Award in the Defense, Transportation and Cybersecurity category at the 2016 CONNECT MIP Awards that took place at an awards ceremony on Dec. 1, in San Diego.

YDreams Global (TSXV: $YD) to use Virtual Reality in the development of simulations for military training
Vancouver, British Columbia - December 1, 2016 (Newsfile Corp.) (Investorideas.com Newswire) YDreams Global Interactive Technologies Inc. (TSXV: YD) (FSE: APYYD) ("YDreams Global" or the "Company"), a creative and technical supplier for Fortune 500 brands such as Cisco, Qualcomm, Intel as well as the Government of Rio de Janeiro, is pleased to announce that it will use its extensive knowledge of Virtual Reality ("VR"), gaming and immersive experiences to develop training solutions for military use.

#DOE Awards $4.5 Million to Supercondcutor Technology (Nasdaq: $SCON) and Partners to Improve HTS Wire for Next Generation Machines
AUSTIN, Texas - November 30, 2016 (Investorideas.com Newswire) Superconductor Technologies Inc. (STI) (Nasdaq:SCON) has been selected as prime recipient of the $4.5 million program award provided by the U.S. Department of Energy's (DOE) Office of Energy Efficiency and Renewable Energy (EERE)

#Drone Stocks: Drone Aviation Holding (OTCQX: $DRNE) Business Update; Commercialization Activities Driving #DoD Customer Backlog Growth
JACKSONVILLE, FL - November 15, 2016 (Investorideas.com Newswire) Drone Aviation Holding Corp. (OTCQX: DRNE) ("Drone Aviation" the "Company" or "DAC"), a manufacturer of tethered drones and lighter-than-air aerostats, today provided the following Business Update from Chairman and CEO, Jay Nussbaum.

US #MarineCorps Selects BLACK BOX (NASDAQ: $BBOX) for Base Infrastructure and Unified Communications Upgrade
PITTSBURGH - November 14, 2016 (Investorideas.com Newswire) Black Box Corporation (NASDAQ: BBOX), a leading technology solutions provider, announced today that it has been awarded a $17.9 million contract from the Marine Corps Systems Command Base Telecommunications Infrastructure (BTI) Program Office to upgrade and expand the existing telecommunication network architecture and systems to a high availability Unified Communications solution at MCB Camp Lejeune, NC.

MYnd Analytics' (OCTCQB: $MYAN) CEO presents at #Defense Entrepreneurs Forum - Silicon Valley; #DEFxSV
PALO ALTO, Calif. - November 11, 2016 (Investorideas.com Newswire) On Saturday, November 12, MYnd Analytics, Inc. (OCTCQB:MYAN) CEO George Carpenter will present at the Defense Entrepreneurs Forum – Silicon Valley (#DEFxSV) hosted at Stanford University.

Global Adaptive #Security Market - Increase in #OnlineAttacks - Expected to Reach $7 Billion by 2020 - Research and Markets
DUBLIN - November 11, 2016 (Investorideas.com Newswire) Research and Markets has announced the addition of the "Global Adaptive Security Market Insights, Opportunity Analysis, Market Shares and Forecast, 2016 - 2022" report to their offering.

#Defense Stock News: Kratos (Nasdaq: $KTOS) Digital IF Demodulator Selected For U.S. #Army Telemetry Modernization Program
SAN DIEGO - November 10, 2016 (Investorideas.com Newswire) Kratos Defense & Security Solutions, Inc. (Nasdaq:KTOS), a leading National Security Solutions provider, announced today that its RT Logic subsidiary was awarded a contract for its Telemetrix 400 Range Receiver (T400RR) equipped with Digital Intermediate Frequency (IF) ingest as part of a program to upgrade an unnamed U.S. Army test site.

#Defense Stock News: CACI (NYSE: $CACI) Awarded $446 Million Prime Contract for Operations, Maintenance, and Sustainment of Air Force Satellite Control Network
ARLINGTON, Va - November 10, 2016 (Investorideas.com Newswire) CACI International Inc (NYSE: CACI) announced today it has been awarded a $446 million prime contract to provide operations, maintenance, and sustainment of the U.S. Air Force Satellite Control Network (AFSCN).

World #Military #Defense $Drones Market (2016-2025) - Likely to Witness a Significant Growth Over the Forecast Years - Research and Markets
DUBLIN - November 10, 2016 (Investorideas.com Newswire) Research and Markets has announced the addition of the "World Military/Defense Drones Market 2016-2025 by UAV Type (MALE, HALE, Tactical), Application (Army, Air Force, Navy & Marine), and Region (North America, APAC, Europe, Latin America, RoW)" report to their offering.

Subscribe to Defense and Security News RSS

Submit Articles   Search More Articles

Biodefense Stock and Industry News from Google News

Stock Quotes

Defense stocks Indices and ETF's

  • PHLX DEFENSE SECTOR INDEX (Philadelphia: ^DFX)
  • S&P Sector Indices Brochure
  • Standard and Poor's 500 Aerospace & Defense Index is a capitalization-weighted index. The index was developed with a base level of 10 for the 1941-43 base period. This is a GICS level 4 sub-industry group. The parent index is SPX. This is a GICS Level 4 Sub-Industry group.
  • The Amex Defense Index (DFI) is an equal dollar weighted Index designed to represent a cross section of widely held, highly capitalized companies involved in providing systems, equipment and services to the United States government and its allies for the purpose of supporting military, defense and intelligence efforts. The component stocks operate in industry segments that include, but are not limited to, military aircraft manufacturing, shipbuilding, ground transportation, aerospace instrumentation and technology, specialized communication and radar systems, ammunition and weapon systems.
  • The iShares Dow Jones U.S. Aerospace & Defense Index Fund seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the Dow Jones U.S. Select Aerospace & Defense Index.
  • The SPADE Defense Index (AMEX: DXS) is a modified market cap-weighted index that was developed to provide a financial benchmark for the performance of companies involved with the defense, homeland security, and space. More than 50 companies currently comprise the index. Information on the Index -- including its methodology, rules, constituents, and performance -- can be found at http://www.spadeindex.com. In October 2005, the first (and currently only) exchange traded fund on defense and homeland security was launched by Powershares. The Powershares Aerospace & Defense Portfolio ETF trades under the symbol 'PPA' and is designed to track the performance of the SPADE. - more info

Sign Up

Sign Up for Investing Ideas & Stock Alerts

Email:

www.Investorideas.com

Biodefense Stocks Directory Preview

Aeolus Pharmaceuticals, Inc ( OTC:AOLS ) is developing a platform of a new class of broad-spectrum, catalytic-antioxidant compounds that protect healthy tissue from the damaging effects of radiation. Its first compound, AEOL 10150, is being developed for oncology indications, where it is used in combination with radiation therapy. It is also being developed, with funding by the US Department of Health and Human Services, as a medical countermeasure against chemical and radiological weapons, where its initial target indications are as a protective agent against the effects of acute radiation syndrome and delayed effects of acute radiation exposure. Aeolus' strategy is to leverage the substantial investment in toxicology, manufacturing, and preclinical and clinical studies made by US Government agencies in AEOL 10150, including the contract with BARDA valued, with options, at up to $118.4 million, to efficiently develop the compound for use in oncology.

Aethlon Medical (NasdaqCM:AEMD) is a leading developer of immunotherapeutic technologies to combat infectious disease and cancer. To augment the body's natural immune defenses, the Aethlon Hemopurifier® eliminates life-threatening disease targets that are often shielded from the immune system and not well addressed by traditional drug therapies. The technology captures circulating viruses, bacterial toxins and cancer promoting exosomes through affinity attachment to a unique structure that cloaks these targets from immune detection. At present, the Hemopurifier® is being advanced under an FDA approved clinical study. Aethlon is also the majority owner of Exosome Sciences, Inc., a company focused on the discovery of exosomal biomarkers to diagnose and monitor life-threatening diseases.

Alexium International Group ( ASX:AJX.AX ) is engaged in developing and licensing its intellectual property, Reactive Surface Treatment (RST) technology. Alexium is focused on developing the RST technology for a range of military and commercial applications. Alexium's Reactive Surface Treatment (RST) is a technology for nanoscopic coatings that combines advanced materials chemistry with a processing step. Alexium's Reactive Surface Treatment (RST) uses cold microwave energy to direct a precursor's polymerization onto a substrate's surface. Its technology is used in textiles, air/fluid filtration, industrial coatings, composite fibers, leather, glass/lens surface treatment, bulk chemicals and thin films. BIODEFENSE: Responding to specific military and first responder needs, Alexium developed the Cleanshell® chemistry to offer a new generation of liquid repellency protection in chemical and biological threat scenarios. Cleanshell® CB is an advanced repellency treatment, optimized for chemical and biological protection. Cleanshell® CB has been optimized to provide excellent water and oil repellency, but has also dramatically increased the repellency of Chemical Warfare Agent (CWA) simulants. Cleanshell® CB offers days of protection versus minutes for conventional fluorocarbon repellency finishes.

American Science and Engineering, Inc ( NasdaqGS: ASEI ) is a leading worldwide supplier of innovative X-ray inspection systems. With over 50 years of experience in developing advanced X-ray security systems, the Company's product line utilizes a combination of technologies, including patented Z Backscatter™ technology, Radioactive Threat Detection (RTD), high energy transmission and dual energy transmission X-ray. These technologies offer superior X-ray threat detection for plastic explosives, plastic weapons, liquid explosives, dirty bombs and nuclear devices. AS&E's complete range of products include cargo inspection systems for port and border security baggage screening systems for facility and aviation security, and personnel and passenger screening systems. AS&E® systems protect high-threat facilities and help combat terrorism, trade fraud, drug smuggling, weapon smuggling, illegal immigration, and people smuggling.

BRUKER Corporation ( NasdaqGS: BRKR ) is a leading provider of high-performance scientific instruments and solutions for molecular and materials research, as well as for industrial, diagnostics and applied analysis. CBRN (Chemical, biological, radiological, and nuclear defense) : The CBRNE threats facing Armed Forces, Emergency and Security Services across the globe are complex. Simple and reliable solutions are required in order to provide protection and fast, effective response. As the market leader in CBRNE for over 20 years, Bruker understand the threat and needs of those operating against it. Our trusted equipment and software is installed around the world providing unrivalled protection. Our equipment is always easy to use and enables full spectrum Detection, Identification and Monitoring utilising state of the art technology.

Cepheid ( NasdaqGS: CPHD ) is a leading molecular diagnostics company that is dedicated to improving healthcare by developing, manufacturing, and marketing accurate yet easy-to-use molecular systems and tests. By automating highly complex and time-consuming manual procedures, the Company's solutions deliver a better way for institutions of any size to perform sophisticated genetic testing for organisms and genetic-based diseases. Through its strong molecular biology capabilities, the Company is focusing on those applications where accurate, rapid, and actionable test results are needed most, such as managing infectious diseases and cancer. BIOTHREATS : The Cepheid GeneXpert® System makes biothreat agent detection possible in minutes — all from unprepared samples. This easy-to-use, automated and highly accurate real-time PCR instrument combines the ingenuity of more than 30 patents into a sophisticated genetic tool for first responders. A patented, disposable, cartridge test for anthrax is available now, and can be performed on-site — delivering critical answers in critical situations.

Cleveland BioLabs, Inc. ( NasdaqCM:CBLI ) is an innovative biopharmaceutical company seeking to develop first-in-class pharmaceuticals designed to address diseases with significant medical need. The company's lead product candidates are Entolimod, which is being developed as radiation countermeasure and a potential cancer treatment and Curaxin CBL0137, our lead oncology product candidate. BIODEFENSE:Entolimod (CBLB502) Biodefense

Dynasil Corporation of America ( NasdaqGM:DYSL ) develops and manufactures detection and analysis technology, precision instruments and optical components for the homeland security, medical and industrial markets. Combining world-class technology with expertise in research and materials science, Dynasil is commercializing products including dual-mode radiation detection solutions for Homeland Security and commercial applications, probes for medical imaging and sensors for non-destructive testing.

Electronic Sensor Technology ( OTC:ESNR) develops, manufactures, and sells electronic devices used for vapor analysis. The company offers zNose, an electronic nose designed for various industry applications, which can detect odors and chemical vapors produced by explosives, chemicals, and biological weapons, as well as used for identifying hazardous industrial materials, improvised explosives, and flammable materials. Its product is used in the homeland security, chemical and petrochemical, environmental, life science, and food and beverage industries. The company also provides spare parts, such as columns, saw detectors, and traps; and accessories, including rugged shipping case, battery assemblies, battery chargers, DC/AC inverters, desorbers, heaters, remote samplers, sample injectors, system controllers, user tool kits, and water traps, as well as support and validation services. Electronic Sensor Technology offers its products through online store.

Emergent BioSolutions, Inc. ( NYSE:EBS ) is a specialty pharmaceutical company seeking to protect and enhance life by offering specialized products to healthcare providers and governments to address medical needs and emerging health threats. The Company provides the world's only FDA-licensed anthrax vaccine to protect against anthrax disease, BioThrax®.

See the full stock directory here